Selina Koch
PersonHeard in 1 episode across 1 show since Oct 2026
Selina Koch, PhD, is an executive editor at BioCentury Inc., where she directs in-depth analytical articles, research, and infographic development. She joined BioCentury after earning a PhD in neuroscience and conducting postdoctoral research at the University of California, San Francisco.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
What Selina Koch has said on podcasts
4 statements
Optogenetics can control specific synaptic circuits.
“it is a way to... control, turn on or off specific synaptic circuits.”
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winnersListen at 24:45
Optogenetics enables investigation of circuit-level mechanisms in neurological diseases.
“you can start to ask questions about, well, what goes wrong at the circuit level in certain kinds of dementias or certain kinds of psychiatric diseases”
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winnersListen at 26:04
Optogenetics can serve as a therapeutic modality in some settings.
“there are a few places where it can be used as a therapeutic modality itself.”
Open the episode · Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winnersListen at 26:27
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Selina Koch, newest first
